시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
세계의 디지털 바이오마커 시장 규모, 점유율, 성장 분석 : 유형별, 임상 실천별, 치료 영역별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)
Digital Biomarkers Market Size, Share, and Growth Analysis, By Type, By Clinical Practice, By Therapeutic Area, By End Users, By Region - Industry Forecast 2025-2032
상품코드 : 1701040
리서치사 : SkyQuest Technology Consulting Pvt. Ltd.
발행일 : 2025년 04월
페이지 정보 : 영문 219 Pages
 라이선스 & 가격 (부가세 별도)
US $ 5,300 ￦ 7,256,000
PDF & Excel (Single User License) help
PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,200 ￦ 8,488,000
PDF & Excel (Multiple User License) help
PDF 및 Excel 보고서를 동일 사업장에서 2-5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,100 ￦ 9,720,000
PDF & Excel (Enterprise License) help
PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

디지털 바이오마커 세계 시장 규모는 2023년 39억 달러, 2024년 50억 2,000만 달러에서 2032년에는 380억 5,000만 달러로 성장하고, 예측 기간(2025-2032년) 동안 28.8%의 연평균 복합 성장률(CAGR)을 보일 것으로 예측됩니다.

디지털 바이오마커 시장은 헬스케어 기술의 급속한 발전과 의료비 증가, 그리고 원격 간호 서비스 및 원격 환자 모니터링에 대한 수요 증가로 인해 강력한 성장세를 보이고 있습니다. 이 시장을 이끄는 주요 요인으로는 분산형 임상시험에 대한 투자 확대, 치료 용도의 확대, 스마트폰 보급에 따른 웨어러블 기기의 급증 등을 들 수 있습니다. 호흡, 음성, 체온, 안구 운동 등 바이탈 지표를 감지할 수 있는 혁신적인 기술로 복잡한 질환의 실시간 모니터링이 가능해졌습니다. 특히 음성을 통한 디지털 바이오마커는 큰 성장 기회를 가지고 있습니다. 룩셈부르크 보건 연구소의 CoLive Voice와 같은 이니셔티브는 원격 위험 평가 및 질병 관리의 잠재력을 강조하고 있습니다. 스마트워치와 피트니스 트래커를 사용하는 소비자가 증가함에 따라 시장은 지속적으로 확대될 준비가 되어 있습니다.

목차

서론

조사 방법

주요 요약

시장 역학과 전망

주요 시장 인사이트

디지털 바이오마커 시장 규모 : 유형별

디지털 바이오마커 시장 규모 : 임상 실천별

디지털 바이오마커 시장 규모 : 치료 영역별

디지털 바이오마커 시장 규모 : 최종사용자별

디지털 바이오마커 시장 규모

경쟁 정보

주요 기업 개요

결론과 제안

LSH
영문 목차

영문목차

Global Digital Biomarkers Market size was valued at USD 3.9 billion in 2023 and is poised to grow from USD 5.02 billion in 2024 to USD 38.05 billion by 2032, growing at a CAGR of 28.8% during the forecast period (2025-2032).

The digital biomarkers market is experiencing robust growth, driven by rising demand for telecare services and remote patient monitoring, alongside rapid advancements in healthcare technology and increased healthcare expenditure. Key factors propelling this market include growing investments in decentralized clinical trials, expanding therapeutic applications, and the surge in wearable devices amid widespread smartphone usage. Innovative technologies capable of detecting vital indicators such as breathing, voice, heat, and eye movements are enabling real-time monitoring of complex diseases. Notably, vocal digital biomarkers present significant growth opportunities. Initiatives like the CoLive Voice by the Luxembourg Institute of Health highlight the potential for remote risk assessment and disease management. With an increasing number of consumers utilizing smartwatches and fitness trackers, the market is poised for continued expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Digital Biomarkers market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Digital Biomarkers Market Segments Analysis

Global Digital Biomarkers Market is segmented by Type, Clinical Practice, Therapeutic Area, End Users and region. Based on Type, the market is segmented into Wearable, Mobile based Applications, Sensors and Others. Based on Clinical Practice, the market is segmented into Diagnostic digital biomarkers, Monitoring digital biomarkers, Predictive and Prognostic digital biomarkers and Others. Based on Therapeutic Area, the market is segmented into Cardiovascular and metabolic disorders (CVMD), Respiratory disorders, Psychiatric disorders, Sleep & Movement Disease, Neurological disorders, Musculoskeletal disorders and Others. Based on End Users, the market is segmented into Healthcare companies, Healthcare Providers, Payers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Digital Biomarkers Market

The rise in the prevalence of diabetes, hypertension, and cardiovascular diseases is driving the demand for digital biomarkers. These advanced health indicators provide essential insights that enable healthcare systems to respond promptly and maintain continuous monitoring of chronic conditions. By facilitating optimal management practices, digital biomarkers empower patients to maintain their health for extended periods and minimize hospital visits. This proactive approach not only enhances patients' quality of life but also helps reduce overall healthcare costs. Consequently, the increasing focus on managing chronic illnesses is significantly fueling the global market for digital biomarkers, highlighting their importance in modern healthcare.

Restraints in the Global Digital Biomarkers Market

While digital biomarkers show significant potential, a major challenge lies in their lack of clinical validation, which is essential for their widespread acceptance among medical professionals. Due to insufficient rigorous research to establish their effectiveness in real-world applications, concerns regarding their accuracy and reliability are prevalent. This gap in validation hinders the broader acceptance and integration of digital biomarkers into standard treatment protocols, as healthcare providers prefer to utilize evidence-based tools that have proven efficacy. Consequently, the limited clinical validation of these biomarkers may impede their ability to gain traction in routine medical practice, posing a significant restraint in the global digital biomarkers market.

Market Trends of the Global Digital Biomarkers Market

The Global Digital Biomarkers market is witnessing a significant trend towards the integration of artificial intelligence (AI), which enhances the capability of wearables and health applications to generate data. By employing advanced AI algorithms to analyze and interpret this data, healthcare providers can uncover patterns and insights that might not be readily apparent, leading to more proactive and individualized healthcare approaches. This trend is pivotal in improving illness management and optimizing patient outcomes, as it amplifies the predictive power of digital biomarkers. Consequently, the market is positioned for robust growth, driven by the increasing reliance on technology for personal health monitoring and disease management.

Table of Contents

Introduction

Research Methodology

Executive Summary

Market Dynamics & Outlook

Key Market Insights

Global Digital Biomarkers Market Size by Type & CAGR (2025-2032)

Global Digital Biomarkers Market Size by Clinical Practice & CAGR (2025-2032)

Global Digital Biomarkers Market Size by Therapeutic Area & CAGR (2025-2032)

Global Digital Biomarkers Market Size by End Users & CAGR (2025-2032)

Global Digital Biomarkers Market Size & CAGR (2025-2032)

Competitive Intelligence

Key Company Profiles

Conclusion & Recommendations

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기